| Date |
Title |
Rating |
| 2011-09-30 |
Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer |
None |
| 2011-09-30 |
FDA, other regulatory and international partners complete International Internet Week of Action |
None |
| 2011-09-30 |
MU researchers examine use of propranolol to improve primary traits linked with autism |
None |
| 2011-09-30 |
Study highlights importance of prior planning before introduction of new vaccines |
None |
| 2011-09-30 |
Patients with chronic hepatitis C less likely to take medications over time |
None |
| 2011-09-30 |
APhA encourages patients to discuss with pharmacist about pain and medications |
None |
| 2011-09-30 |
Survey: 25% of employers have little or no understanding of specialty pharmacy, costs |
None |
| 2011-09-30 |
Resveratrol inhibits proliferation of hormone resistant breast cancer cells |
None |
| 2011-09-30 |
Cocaine use linked to increased risk of open-angle glaucoma |
None |
| 2011-09-30 |
Oral steroid users twice as likely to have severe vitamin D deficiency |
None |
| 2011-09-30 |
Invida, Sinclair IS launch two dermatology products in seven Asia-Pacific markets |
None |
| 2011-09-30 |
AstraZeneca settles SEROQUEL XR patent infringement litigation |
None |
| 2011-09-30 |
Beta-blockers can prevent breast cancer metastasis and improve survival |
None |
| 2011-09-29 |
Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors |
None |
| 2011-09-29 |
Bulgaria’s decades old anti-smoking pill could be a cheap and effective answer to smoking cessation |
5 |
| 2011-09-29 |
FDA CDER assigned for pre-market review of CorMedix's Neutrolin |
None |
| 2011-09-29 |
Almirall seeks European approval for linaclotide to treat irritable bowel syndrome with constipation |
None |
| 2011-09-29 |
Oral tenofovir discontinued in HIV clinical trial |
None |
| 2011-09-29 |
Public lecture on children's medicines to be launched on October 5 |
None |
| 2011-09-29 |
SIS becomes an Industry Supporter of ASA |
None |
| 2011-09-29 |
New report finds little evidence to support off-label use of atypical antipsychotics |
None |
| 2011-09-29 |
AASLD publishes updated practice guidelines on hepatitis C |
None |
| 2011-09-29 |
Prototype drug shows promise against chronic lymphocytic leukemia |
5 |
| 2011-09-29 |
Acetyl-L-carnitine likely to improve outcomes and recovery for individuals with SCI |
None |
| 2011-09-29 |
Johns Hopkins researchers discover oxaliplatin-based nerve damage |
None |
| 2011-09-28 |
Valeant's colesevelam New Drug Submission for hypercholesterolemia receives Canadian approval |
None |
| 2011-09-28 |
FDA: Study suggests increased risk of blood clots from drospirenone-containing contraceptives |
None |
| 2011-09-28 |
'Urgent action' needed to prevent resistance to antiretroviral therapy |
None |
| 2011-09-28 |
Americans cutting back on health spending by skipping prescriptions, procedures |
None |
| 2011-09-28 |
Postmenopausal HRT linked with increased risk of asthma hospitalisations in women |
None |
| 2011-09-28 |
UCI professor wins Presidential Early Career Award for Scientists & Engineers |
None |
| 2011-09-28 |
Stimulant prescription use for ADHD has increased steadily from 1996-2008 |
None |
| 2011-09-28 |
Transcept announces resubmission of NDA for Intermezzo to FDA |
None |
| 2011-09-28 |
Benefits and harms vary among atypical antipsychotics for off-label use |
None |
| 2011-09-28 |
DMARDs appear to be more effective for children with arthritis |
None |
| 2011-09-28 |
Asians struggling with alcoholism may benefit from naltrexone |
None |
| 2011-09-28 |
Study sheds light on when to start antiretroviral therapy |
None |
| 2011-09-27 |
Researchers hack genetic code that controls immune response to measles vaccination |
None |
| 2011-09-27 |
Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer |
None |
| 2011-09-27 |
MSU creates new malaria vaccine with immune-stimulating gene |
None |
| 2011-09-26 |
Link between changes in malaria parasite and absorption of pharmaceutical compounds |
None |
| 2011-09-26 |
New insights into actions of NSAIDs |
None |
| 2011-09-26 |
Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine |
None |
| 2011-09-26 |
Isis files patent infringement lawsuit against Santaris for antisense drugs |
None |
| 2011-09-26 |
Cannabidiol may help prevent paclitaxel-induced peripheral neuropathy |
None |
| 2011-09-26 |
No link between duration or depth of general anesthesia and subsequent cancer risk |
None |
| 2011-09-26 |
Self-reported mental health disability more prevalent among U.S. adults |
None |
| 2011-09-26 |
Sodium Stibogluconate & Paromomycin combination treatment for Kala azar |
1 |
| 2011-09-26 |
Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study |
None |
| 2011-09-26 |
Primatene inhalers to be phased out this December: FDA |
None |
| 2011-09-26 |
EMA CHMP adopts positive opinion for Optimer's DIFICLIR to treat C. difficile infection |
1 |
| 2011-09-26 |
CytoDyn files provisional patent application for humanized version of Cytolin to treat HIV |
None |
| 2011-09-26 |
Janssen Biotech receives FDA approval for Remicade to treat UC in children |
None |
| 2011-09-26 |
Alexion receives FDA approval for Soliris to treat atypical Hemolytic Uremic Syndrome |
None |
| 2011-09-23 |
EMA CHMP adopts positive opinion for Soliris to treat atypical hemolytic uremic syndrome |
None |
| 2011-09-23 |
Gilead announces EMA CHMP positive opinion for HIV-1 drug, Eviplera |
None |
| 2011-09-23 |
Drug shortages fuel increases in cost of care, poor outcomes |
None |
| 2011-09-23 |
FDA denies FOIA regarding Gilead Sciences' Truvada correspondence, AHF sues |
None |
| 2011-09-23 |
Bachmann, Perry wrestle over HPV issue |
None |
| 2011-09-23 |
Momenta, Sandoz file patent suit against Amphastar and Watson over Enoxaparin Sodium Injection |
None |
| 2011-09-23 |
Study identifies genetic mutations that affect immune response to measles vaccination |
None |
| 2011-09-23 |
IU professor to study factors influencing young women's adoption of HPV vaccine |
None |
| 2011-09-23 |
CoPlex, Hawthorn sign license agreement for hawAD14 Alzheimer's drug |
None |
| 2011-09-23 |
Adamis receives patents for APC-200 prostate cancer drug in South Africa, Singapore |
None |
| 2011-09-23 |
Shire announces update on approval status and availability of ProAmatine SOH drug |
None |
| 2011-09-23 |
Bortezomib drug may also treat pulmonary fibrosis or scleroderma |
None |
| 2011-09-23 |
Study: Opioid drugs can increase risk of pneumonia in older adults |
None |
| 2011-09-23 |
USPTO issues patent for Lixte's LB-100 to treat cancer |
None |
| 2011-09-22 |
Anti-obesity drug Contrave may get another chance to prove itself |
None |
| 2011-09-22 |
Jefferson experts review most commonly used CAM practices for mood disorders |
None |
| 2011-09-22 |
New portable test can quickly and economically detect adulterated heparin |
None |
| 2011-09-22 |
Early ART cost effectiveness in resource-poor settings |
None |
| 2011-09-22 |
Humour therapy as effective as antipsychotic drugs in managing agitation in dementia patients |
None |
| 2011-09-22 |
Cannabinoids may block development of PTSD symptoms after traumatic experience |
None |
| 2011-09-22 |
Methylphenidate drug may induce arousal from general anesthesia |
None |
| 2011-09-22 |
Early ART can be cost-effective and decrease mortality in HIV patients |
None |
| 2011-09-22 |
Digna Biotech receives FDA Orphan Drug status for cardiotrophin-1 to treat ALF |
None |
| 2011-09-22 |
Ariel Pharmaceuticals in-licenses AP-1531 from BTG for acute migraine attacks |
None |
| 2011-09-22 |
Hoffman La Roche, Mylan enter settlement and license agreement for XELODA Tablets |
None |
| 2011-09-22 |
Peptide receptor radiolabeled therapy shows promise against neuroendocrine tumors |
None |
| 2011-09-22 |
NIH to honor IGB faculty member with innovator award |
None |
| 2011-09-21 |
Combination of SRIs and cognitive behavior therapy reduces pediatric OCD symptoms |
None |
| 2011-09-21 |
Long-term immunosuppressants improve survival for lupus patients with ESKD |
None |
| 2011-09-21 |
Influential leaders hold high-level discussions on biomedical S&T initiatives |
None |
| 2011-09-21 |
New FDA-approved antiviral drugs offer treatment hope for hepatitis C |
None |
| 2011-09-21 |
St. Jude Medical pledges $100,000 to support SIR Foundation's Discovery Campaign |
None |
| 2011-09-21 |
UNC's new nanoparticle shows potential for cancer chemotherapy |
None |
| 2011-09-21 |
African-American men living in low sunlight areas more likely to have Vitamin D deficiency |
None |
| 2011-09-21 |
Matrix receives FDA's tentative approval for novel co-packaged version of HIV/AIDS therapy |
None |
| 2011-09-21 |
Beta-blocker drugs may improve survival time for melanoma patients |
None |
| 2011-09-20 |
Nuevolution announces collaboration in drug discovery with Boehringer Ingelheim |
None |
| 2011-09-20 |
Whooping cough vaccine may lose protective capacity in 3 years: Study |
None |
| 2011-09-20 |
Qualitest recalls birth control pills citing “packaging error” |
None |
| 2011-09-20 |
Regulatory bias against taking oral anti-cancer medications with food places patients at risk of overdose |
None |
| 2011-09-20 |
Medication non-adherence interventions should be based on personal systems approach |
None |
| 2011-09-20 |
Combination of lunasin and oxaliplatin prevents colon cancer from metastasis |
None |
| 2011-09-20 |
FoxM1 protein plays a critical role in development of medulloblastomas |
None |
| 2011-09-20 |
New UTHealth toll-free helpline for pregnant women to avoid dangerous medications |
None |
| 2011-09-20 |
Powerful new antibiotic treatment for MRSA and C. difficile bugs |
None |
| 2011-09-20 |
FDA approves Amphastar's ANDA for Enoxaparin Sodium Injection |
None |
| 2011-09-19 |
Revolution in drug discovery underway in West Midlands, UK |
None |
| 2011-09-19 |
Too many kids poisoned with prescription drugs: Study |
None |
| 2011-09-19 |
Amgen's Prolia receives FDA approval for new indications to treat cancer patients |
None |
| 2011-09-19 |
Amneal announces availability of generic antiepileptic drug, Felbamate |
None |
| 2011-09-19 |
Meda acquires exclusive licensing rights to Nalox from Moberg Derma |
None |
| 2011-09-19 |
Alkermes establishes business operations in Ireland |
None |
| 2011-09-19 |
Low-dose anticholinergic drugs do not appear to cause cognitive impairment in dementia patients |
None |
| 2011-09-19 |
USPTO issues notice of allowance to Cenestra Health's omega-3 fatty acid formulations |
None |
| 2011-09-19 |
Meda, Moberg Derma enter license agreement for Nalox to treat onychomycosis |
None |
| 2011-09-19 |
Safety tips to prevent unintentional pediatric medication poisonings |
None |
| 2011-09-19 |
Two newer Type 2 diabetes drugs could be linked to increased risk of pancreatic cancer |
None |
| 2011-09-17 |
Bioethicists up the ante in Bachmann's HPV brouhaha |
None |
| 2011-09-17 |
BARDA awards Vaxin $21.7M contract to accelerate development of novel anthrax vaccine |
None |
| 2011-09-16 |
Anti-nausea drug Zofran being tested for its potential heart rhythm side effects |
None |
| 2011-09-16 |
DryDiapersPlus joins Unique Wellness and BIOTX to provide incontinence products |
None |
| 2011-09-16 |
ONGLYZA used with insulin maintains improvement in glucose control in adults with type 2 diabetes |
None |
| 2011-09-16 |
HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin |
None |
| 2011-09-16 |
Researchers develop polymers that fluoresce in the presence of bacteria |
None |
| 2011-09-16 |
Karolinska Institutet professor earns 2011 ECNP Neuropsychopharmacology Award |
None |
| 2011-09-16 |
Study shows increase in pediatric medication poisoning |
None |
| 2011-09-16 |
Estrogen therapy can reverse progression of pulmonary hypertension |
None |
| 2011-09-16 |
New paper describes unique process that is central to induction of MSRA antibiotic resistance |
None |
| 2011-09-16 |
Teva to invest in CDI for development of novel antiviral drugs |
None |
| 2011-09-16 |
GSA's two forthcoming publications focus on pain relief and medication for seniors |
None |
| 2011-09-16 |
New study aims to reduce number of pediatric pharmaceutical poisoning |
None |
| 2011-09-16 |
Medicated stents lower likelihood of heart attacks in cardiac patients |
5 |
| 2011-09-15 |
Synthon announces European approvals for Eplerenone |
None |
| 2011-09-15 |
VBI Vaccines completes acquisition of Epixis |
None |
| 2011-09-15 |
Positive results from PROLOR Biotech's Factor VIIa-CTP preclinical study on hemophilia |
None |
| 2011-09-15 |
Pfizer awards 2011 fellowship to UH Case Medical Center for pain medicine and epilepsy |
None |
| 2011-09-15 |
JCPT publishes 'The Need for Increased Utilization of Statins After Occlusive Stroke' study |
None |
| 2011-09-15 |
CHK Nutrition, NeuroResearch Clinics sign consent to halt sale of unapproved amino-acid products |
4.5 |
| 2011-09-15 |
ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload |
None |
| 2011-09-15 |
Scientists report development of three new formulations against methamphetamine abuse |
None |
| 2011-09-15 |
UIC researchers to conduct study on televised drug commercials |
None |
| 2011-09-15 |
Viewpoints: Shredding Bachmann's vaccine argument; 'super' or 'stupor' committee; Bennet on outmoded drug safety rules |
None |
| 2011-09-15 |
Researchers discover several chemical compounds against human prion diseases |
5 |
| 2011-09-14 |
New Zealand biotechnology company moves to US |
None |
| 2011-09-14 |
Lucentis receives Health Canada approval to treat vision loss from DME |
None |
| 2011-09-14 |
Cohera's TissuGlu Surgical Adhesive receives CE Mark approval |
None |
| 2011-09-14 |
Celecoxib inhibits GSK3 enzyme in lung cancer cells |
None |
| 2011-09-14 |
Reminder packaging improves adherence to long-term hypertension medications |
None |
| 2011-09-14 |
FDA grants Orphan Drug Designation for Accentia's Revimmune to prevent GVHD |
None |
| 2011-09-14 |
Biotica, Buck Institute collaborate to investigate polyketides in diseases of aging |
None |
| 2011-09-14 |
Natural S-equol supplement does not increase risk of estrogen-sensitive breast cancer |
None |
| 2011-09-14 |
Merck issues statement on GARDASIL human papillomavirus vaccine |
None |
| 2011-09-14 |
Prescription drugs expensive in Australia and likely to increase |
None |
| 2011-09-14 |
Avedro acquires proprietary and patent pending transepithelial ParaCel riboflavin formulation |
None |
| 2011-09-14 |
Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children |
None |
| 2011-09-14 |
Kremers Urban reaches settlement agreement with ALZA over Concerta patent litigation |
None |
| 2011-09-13 |
FDA’s response to Tobacco company’s allegations on graphic cigarette labels |
None |
| 2011-09-13 |
Older drugs may be better than newly approved ones |
None |
| 2011-09-13 |
FDA announces organizational changes within CDER's Office of Oncology Drug Products |
None |
| 2011-09-13 |
New drug combination may treat two aggressive cancers |
4 |
| 2011-09-13 |
Researchers identify new type of potential anticancer drug |
None |
| 2011-09-13 |
Cardiotrophin 1 has marked effect on fat and glucose metabolism |
5 |
| 2011-09-13 |
Hawthorn, CoPlex Therapeutics sign licensing deal to develop and commercialize hawAD14 for Alzheimer's |
None |
| 2011-09-13 |
Impax confirms JALYN patent challenge |
3 |
| 2011-09-12 |
Micronutrient powder helps prevent malnutrition in children up to two years old, study review shows |
None |
| 2011-09-12 |
Lantus initiation may help limit weight gain in type 2 diabetes patients |
None |
| 2011-09-12 |
Low-dose aspirin increases risk for GI bleeding |
None |
| 2011-09-12 |
Health Canada approves Merus Labs' advanced wound care product, Collexa |
None |
| 2011-09-12 |
Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma |
None |
| 2011-09-12 |
InterMune to launch Esbriet for German patients with IPF |
None |
| 2011-09-12 |
Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma |
None |
| 2011-09-12 |
Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy |
None |
| 2011-09-12 |
EpiCept announces FDA's feedback on Ceplene clinical development for AML |
None |
| 2011-09-12 |
FDA advisory panel suggests warning for bisphosphonates but does not specify wording |
None |
| 2011-09-12 |
Pew Health Group to ensure safety of U.S. drug supply |
None |
| 2011-09-12 |
General anesthesia can cause cognitive impairment in children |
None |
| 2011-09-12 |
Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy |
None |
| 2011-09-12 |
FDA grants orphan drug designation for Avedro's VibeX to treat Keratoconus |
None |
| 2011-09-12 |
PharmAthene completes 1,500 liter engineering production run for SparVax anthrax vaccine |
None |
| 2011-09-12 |
Candidate malaria vaccine represents 'potentially encouraging anti-malaria strategy,' researchers say |
None |
| 2011-09-12 |
Access to lifesaving generic medicines threatened by U.S. trade pact |
None |
| 2011-09-12 |
Study pinpoints relationship between primary brain tumors and onset of epileptic seizures |
None |
| 2011-09-09 |
FDA panel votes 9-2 in favor of new blood thinner drug |
None |
| 2011-09-09 |
HPV vaccination updates |
None |
| 2011-09-09 |
AstraZeneca Canada introduces new NEXIUM Patient Support program |
None |
| 2011-09-09 |
FDA grants final approval for Mylan's Promethazine HCl Tablets |
None |
| 2011-09-09 |
Astex selects PharmaVentures to assist in divesment of CMC & Formulation Facility |
None |
| 2011-09-09 |
SAMHSA survey finds increase in use of illicit drugs among Americans between 2008-2010 |
None |
| 2011-09-09 |
Elusys receives federal contract to develop prophylactic treatment against anthrax |
None |
| 2011-09-09 |
Possible link between mother's diet and risk of allergies in children |
None |
| 2011-09-08 |
Auxilium reports positive data from XIAFLEX retrospective commercial patient chart review |
None |
| 2011-09-08 |
Naturopathic medicine helps reduce doctors' use of prescription drugs |
None |
| 2011-09-08 |
EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis |
None |
| 2011-09-08 |
Researchers uncover new and safe contraceptive pill for women |
None |
| 2011-09-08 |
Scientists discover backup circuits in cetuximab-resistant cancer cells |
None |
| 2011-09-08 |
Inhibition of Sab protein protects liver from acetaminophen toxicity |
None |
| 2011-09-08 |
First-ever comprehensive study of species origins of nature-derived drugs |
None |
| 2011-09-08 |
Beta-glucans can help wounds to heal quickly |
5 |
| 2011-09-07 |
Researchers rethink fenretinide for prevention of oral cancer |
None |
| 2011-09-07 |
BioLineRx, Tel Aviv University sign license agreement to develop and commercialize BL-7050 |
None |
| 2011-09-07 |
Cheap medicines could prevent huge number of deaths from heart attacks, strokes |
None |
| 2011-09-07 |
Genetically modified M. smegmatis vaccine shows promise against TB |
None |
| 2011-09-07 |
Use of nonaspirin NSAIDs during early pregnancy raises risk of miscarriage in women |
None |
| 2011-09-07 |
Drugs produced in offshore manufacturing plants more likely to have quality problems |
None |
| 2011-09-07 |
Oxycodone no safer than codeine for breastfed infants: New study |
None |
| 2011-09-06 |
FDA reviews safety issues of bisphosphonates for osteoporosis |
None |
| 2011-09-06 |
FDA stalls the blood-thinner Xarelto’s approval citing inadequate evidence |
None |
| 2011-09-06 |
Discovery Labs files Complete Response to FDA for SURFAXIN to treat RDS in premature infants |
None |
| 2011-09-06 |
NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission |
None |
| 2011-09-06 |
Amakem receives €18m in Series A round of funding |
None |
| 2011-09-06 |
Scale-up Systems establishes new office in India |
None |
| 2011-09-05 |
Study aims to describe and understand current issues on OTC medicine addiction |
None |
| 2011-09-05 |
IKEPLUS immunization completely eliminates TB bacteria from infected tissues |
None |
| 2011-09-05 |
Berlin to market wide range of Acino Pharma's current and future products in Thailand |
None |
| 2011-09-03 |
Researchers discover mechanism of low-dose LDN on cell proliferative-related disorders |
5 |
| 2011-09-03 |
Resveratrol helps prevent metabolic syndrome in offspring |
None |
| 2011-09-03 |
Finland national health institute finds link between H1N1 flu vaccine and children's narcolepsy |
None |
| 2011-09-03 |
Plerixafor drug shows promise against WHIM syndrome |
None |
| 2011-09-02 |
Mayo Clinic and IC-MedTech enter collaborative research agreement with Summa Health System |
None |
| 2011-09-02 |
PTC restructures collaboration with Genzyme |
None |
| 2011-09-02 |
Western, Midwestern states register higher methamphetamine usage |
None |
| 2011-09-02 |
Researchers modify toxic chemical of marine cycyanobacteria to treat colon cancer |
None |
| 2011-09-02 |
Florida steps up efforts against pill mills; Hospital executives under scrutiny |
None |
| 2011-09-02 |
Microtubule stability linked to increased sensitivity to paclitaxel |
None |
| 2011-09-02 |
Contraceptive pill prevents loss of eye sight |
3.5 |
| 2011-09-02 |
Pemetrexed treatment produces better outcomes in ALK-translocated NSCLC patients |
None |
| 2011-09-02 |
Short-term glucocorticoid treatment may prevent osteoarthritis after joint injury |
None |
| 2011-09-02 |
'Sustainable global pharmacovigilance' systems needed to monitor ARVs, other drugs |
None |
| 2011-09-02 |
UC Davis computer model can test effects of anti-arrhythmia medications |
None |
| 2011-09-02 |
FTC presses for more competition on generic drugs |
None |
| 2011-09-02 |
Ancient antibiotic resistance findings leads experts to stress need to use antibiotics sparingly |
None |
| 2011-09-02 |
FDA approves crizotinib for treatment of ALK-positive lung cancer |
None |
| 2011-09-02 |
Dendritic cells play central role in regulation of acetaminophen's toxicity |
None |
| 2011-09-02 |
Stomach acid-reducing drugs appear to cause small intestine damage |
None |
| 2011-09-02 |
LCA applauds FDA approval of Xalkori for ALK positive non-small cell lung cancer |
None |
| 2011-09-02 |
FDA may be allowed an extra 2 months to review new drugs |
None |